サカイ ケン
Sakai Ken
酒井 謙 所属 東邦大学 医学部 医学科(大森病院) 職種 教授 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Combined Therapy with Peritoneal Dialysis and Hemodialysis: A Multicenter Retrospective Observational Cohort Study in Japan |
掲載誌名 | 正式名:Blood purification 略 称:Blood Purif ISSNコード:02535068/14219735 |
出版社 | Karger |
巻・号・頁 | 38(2),pp.149-153 |
著者・共著者 | Maruyama Y.a, b · Yokoyama Ka, b · Nakayama M.c · Higuchi C.d · Sanaka T.d · Tanaka Y.e · Sakai K.e · Mizuiri S.e · Otsuka Y.a · Kuriyama S.a · Maeba T.f · Iwasawa H.g · Nakao T.g · Hosoya T.b · for the EARTH (Evaluation of the Adequacy of Renal replacement THerapy) study group |
発行年月 | 2014/06 |
概要 | Combining peritoneal dialysis (PD) and hemodialysis (HD) has been common treatment option in Japan. Methods: In this retrospective, multicenter, observational study, the clinical characteristics and outcomes of 104 patients (57 w 11 years, males 72) who had switched from PD alone to combined therapy with PD and HD were studied. Clinical parameters were measured at baseline and after 3 months of combined therapy. Results: At baseline, urine volume, dialysate-to-plasma ratio of creatinine (D/P Cr), and total Kt/V were 150 ml/day (range: 0-2,000 ml/day), 0.67 w 0.11, and 1.8 w 0.4, respectively. During the first 3 months of combined therapy, body weight, urine volume, serum creatinine level, and D/P Cr decreased, whereas hemoglobin levels increased. Conclusions: In patients where PD does not result in acceptable outcomes, combined therapy with PD and HD may have potential benefits in terms of dialysis adequacy and hydration status. |
DOI | 10.1159/000368389 |